Mr. DeMartino will step into his role Sept. 9 and will develop, refine and lead the company’s investor relations strategy. He has more than 25 years of experience in the healthcare industry and was most recently chief strategy officer at Nyxoah.
Mr. DeMartino also has experience working in private company investments, sell-side equity research and medical devices.
“His impressive career achievements and extensive knowledge of the medtech industry, as both an investor and in equity research, make him the ideal candidate for this strategically important position,” CEO Ivan Tornos said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
